Value of Hu antibody determinations in the follow-up of paraneoplastic neurologic syndromes

Neurology

Volumn 63, Issue 10, 2004, Pages 1947-1949

  Llado A ^a   Mannucci, P ^a   Carpentier, A F ^b   Paris, S ^b   Blanco, Y ^a   Saiz, A ^a   Delattre, J Y ^b   Graus, F ^a,c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; HU ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER REGRESSION; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; MALE; PARANEOPLASTIC NEUROPATHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 8844240580     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000144340.03364.BF     Document Type: Article

References (10)

1. Dalmau J, Gultekin HS, Posner JB. Paraneoplastic neurologic syndromes: pathogenesis and physiopathology. Brain Pathol 1999;9:275-284.
2. Yagi Y, Inuzuka T, Takada K, et al. Changes in anti-HuD antibody titers in the long-term course in paraneoplastic sensory neuropathy. Eur Neurol 1997;37:122-123.
3. Rauer S, Czygan M, Kaiser R. Quantification of circulating anti-Hu antibody in serial samples from patients with paraneoplastic neurological syndromes: possible correlation of antibody concentration and course of neurological symptoms. J Neurol 2002;249:285-289.
4. Uchuya M, Graus F, Vega F, Reñé R, Delattre JY. Intravenous immunoglobulin treatment in paraneoplastic neurologic syndromes with antineuronal antibodies. J Neurol Neurosurg Psychiatry 1996;60:388-392.
5. Graus F, Keime-Guibert F, Reñé R, et al. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain 2001;124:1138-1148.
6. Graus F, Dalmau J, Reñé R, et al. Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival. J Clin Oncol 1997;15:2866-2872.
7. Graus F, Bonaventura I, Uchuya M, et al. Indolent anti-Hu-associated paraneoplastic sensory neuropathy. Neurology 1994;44:2258-2261.
8. Lucchinetti CF, Kimmel DW, Lennon VA. Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear antibodies. Neurology 1998;50:652-657.
9. Bataller L, Graus F, Saiz A, Vilchez JJ. Spanish Opsoclonus-Myoclonus Study Group. Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus. Brain 2001;124:437-443.
10. Verschuuren JJ, Perquin M, Velde G, De Baets M, Breda-Vriesman P, Twijnstra A. Anti-Hu antibody titre and brain metastases before and after treatment for small cell lung cancer. J Neurol Neurosurg Psychiatry 1999;67:353-357.